Artificial Intelligence (AI) has emerged as a powerful tool in modern chemical research, significantly

accelerating the discovery and development of new drugs and advanced materials. Traditional experimental

approaches in chemistry are often time-consuming, expensive, and require extensive trial-and-error processes.

AI techniques, particularly machine learning and deep learning, enable researchers to analyse large chemical

datasets, predict molecular properties, and identify potential compounds with greater efficiency and accuracy. In

drug discovery, AI helps in predicting drug–target interactions, optimizing molecular structures, and reducing

the time required for lead identification. Similarly, in materials science, AI assists in designing novel materials

with desired properties for applications in energy storage, catalysis, and electronics.

This paper highlights the role of AI-driven computational models in transforming chemical research, discusses

molecular structures, chemical reactions, and material properties. While these methods have led to numerous

scientific breakthroughs, they are often time-consuming, costly, and require extensive laboratory

experimentation. The rapid growth of digital chemical databases and computational technologies has created

new opportunities to accelerate chemical research [1]. In recent years, Artificial Intelligence (AI) has emerged

as a transformative tool in chemistry, enabling researchers to analyze large volumes of chemical data, identify

hidden patterns, and make accurate predictions that support faster scientific discovery.

Artificial Intelligence refers to computer systems capable of performing tasks that typically require human

intelligence, such as learning from data, recognizing patterns, and making decisions. In chemical research, AI

techniques-particularly machine learning (ML) and deep learning (DL) are increasingly used to model complex

chemical systems and predict molecular behaviour [2]. These methods can process massive datasets of chemical

drug candidates. AI can dramatically accelerate this process by predicting drug-target interactions, identifying

potential therapeutic molecules, and optimizing molecular structures for improved efficacy and safety [4-5].

Machine learning algorithms can analyse biological and chemical datasets to identify patterns that indicate how

specific molecules may interact with proteins or disease targets. By narrowing down the number of compounds

that require experimental testing, AI significantly reduces both the time and cost involved in developing new

medicines.

In addition to pharmaceutical research, AI is also transforming the field of materials science. The discovery of

advanced materials-such as catalysts, semiconductors, battery materials, and nanomaterials-traditionally requires

extensive experimental testing and theoretical modelling. AI techniques enable researchers to predict the

physical and chemical properties of materials before they are synthesized in the laboratory. Through data-driven

Overall, the integration of artificial intelligence with chemical sciences represents a major paradigm shift in how

chemical research is conducted. By combining advanced computational algorithms with large-scale chemical

data, AI has the potential to significantly accelerate the discovery of new drugs and advanced materials. As

computational power, data availability, and algorithmic techniques continue to improve, AI is expected to play

an increasingly important role in shaping the future of chemistry, enabling faster innovation, more efficient

research processes, and the development of solutions to critical global challenges in healthcare, energy, and

environmental sustainability [7].

Artificial Intelligence (AI) has emerged as a transformative tool in chemical sciences, particularly in drug

discovery and materials design. With the rapid growth of chemical databases and computational power, machine

effectively analyse large molecular datasets [9]. AI also supports de novo drug design and drug repurposing,

reducing development time and improving candidate selection efficiency.

AI has also accelerated progress in materials science by predicting properties such as stability, conductivity, and

mechanical strength before experimental synthesis. Machine learning models assist in discovering battery

materials, nanomaterials, polymers, and catalysts, enabling structure–property analysis and high-throughput

screening for efficient material design [10].

Computational Techniques Used

6. Data mining and predictive modelling.

These approaches analyse large experimental and computational datasets to enhance chemical research

efficiency.

Several Artificial Intelligence (AI) techniques are widely used to accelerate drug and materials discovery.

Machine Learning (ML) is the most commonly applied technique in chemistry and is used for predicting

molecular properties [11-12], drug-target interactions, toxicity, and material property estimation. Common ML

molecular property prediction, reaction prediction, drug discovery, and materials design. Additionally, predictive

modelling and data mining techniques help analyse large chemical datasets to identify structure-property

relationships, screen compound libraries, and optimize materials. Generative AI models, such as Variational

Autoencoders (VAE), Generative Adversarial Networks (GANs), and Transformer-based models, are used for

de novo drug design and novel material generation. Finally, Reinforcement Learning (RL) is applied in

optimization tasks, including reaction optimization, molecular design, and automated laboratory systems.

Overall, the most commonly used techniques in research include Machine Learning, Deep Learning, Graph

Neural Networks, Generative Models, and Reinforcement Learning.

The Artificial Intelligence (AI) significantly improves the efficiency of drug and materials discovery. Machine

learning and deep learning models demonstrate high accuracy in predicting molecular properties, drug-target

in chemical research.

1. Burki, T. (2019). Pharma blockchains AI for drug development. The Lancet, 393, 2382.

https://doi.org/10.1016/S0140-6736(19)31160-8

2. Butler, K. T., Davies, D. W., Cartwright, H., Isayev, O., & Walsh, A. (2018). Machine learning for

molecular and materials science. Nature, 559(7715), 547–555.

https://doi.org/10.1038/s41586-018-0337-

2

3. Chakravarty, K., Antontsev, V. G., Khotimchenko, M., et al. (2021). Accelerated repurposing and drug

analysis on high-resolution UPLC-MSE/QTOF mass spectrometry. Journal of Applied Laboratory

Medicine, 8(1), 53–66. https://doi.org/10.1093/jalm/jfac119

6. Hong, E., Jeon, J., & Kim, H. U. (2023). Recent development of machine learning models for the

prediction of drug–drug interactions. Korean Journal of Chemical Engineering, 40, 276–285.

https://doi.org/10.1007/s11814-022-1285-4

7. Jiménez-Luna, J., Grisoni, F., & Schneider, G. (2020). Drug discovery with explainable artificial

intelligence. Nature Machine Intelligence, 2(10), 573–584.

https://doi.org/10.1038/s42256-020-00236-4

8. Liu, Z., Roberts, R. A., Lal-Nag, M., Chen, X., Huang, R., & Tong, W. (2021). AI-based language models

powering drug discovery and development. Drug Discovery Today, 26(11), 2593–2607.